SPEAKERS

 

 

The 2017 line-up includes speakers from the Immune Profiling World Congress, World Vaccine Congress Europe and World Veterinary Vaccine Congress.

Jeffrey D Abbey, President and Chief Executive Officer, Argos Therapeutics

Jeffrey D Abbey, President and Chief Executive Officer, Argos Therapeutics

Dr Rachel Abbott, Group Leader, Preclinical Research, Adaptimmune Ltd

Kunal Aggarwal, Head of Technical R&D Programs - R&D Center USA, GSK Vaccines

Dr Osama Ahmed Hassan Ahmed, Epidemiologist, Center for Global Health, Department of Community Medicine and Global Health, University of Oslo

Prof Jeffrey Almond, Former Vice President Discovery Research and Development, Sanofi and Visiting Professor, University of Oxford - Oxford Vaccine Group

Dr Marisa Arias Neira, Technical Director, Instituto Nacional De Investigacion Agraria Y Alimentaria

Dr Philip Arlen, President and Chief Executive Officer, Precision Biologics Inc

Dr Florence Arvis, Head of Formulation Unit, Sanofi Pasteur Sa

Dr Jean-Christophe Audonnet, Senior Director, Research Strategy and Key Alliances, Bio R&D and Coordinatior at ZAPI, Merial

Dr Jean-Christophe Audonnet, Senior Director, Research Strategy and Key Alliances, Bio R&D and Coordinatior at ZAPI, Merial

Dr Arnaud Bataille, Researcher in Virology, C.I.R.A.D.

Dr Norman Begg, Vice President, Head of Scientific Affairs and Public Health, GSK Vaccines

Dr Suresh Beri, Additional Director of Polysaccharide Conjugate Vaccine, Serum Institue Of India

Prof Sumi Biswas, Associate Professor, University of Oxford

Dr Anissa Boumlic-Courtade, Vaccine Market Lead, EMEA, MERCK

Dr Christian Brander, CSO Aelix Therapeutics, ICREA Research Professor, IrsiCaixa A.I.D.S. Research Institute

Dr James Brooks, Research and Development Manager, BD Biosciences

Adam Buckley, VP Business Development, VBI Vaccines

Dr Rosario Bullido, Head of Veterinary Inmunological Medicines Assessment Unit Veterinary Medicines Department, Aemps

Dr Rosario Bullido at Immune Profiling World Congress

Miles Carroll, Deputy Director, Public Health England

Francesca Ceddia, VP, Head Global Medical Affairs Vaccines, GSK Vaccines

Dr Brian Champion, CSO, Psioxus Therapeutics

Dr Brian Champion at Immune Profiling World Congress

Dr Brian Champion, CSO, Psioxus Therapeutics

Catherine Charreyre, Head of Research Projects, Merial

Anne Chevrel, Research and Development Project Manager, Affilogic

Anne Chevrel at Immune Profiling World Congress

Trevor Clancy, Co Founder and Chief Scientific Officer, OncoImmunity

Gillian Cowan, Regulatory Affairs Consultant, Global Alliance For Livestock Veterinary Medicines

Dr Sandrine Crabe, Research & Development Director, ABIVAX

Prof Ron Dagan, head, pediatric Infectious diseases, Ben Gurion University

Angus Dalgleish, Foundation Chair in Clinical Oncology + Research Director, St George's University, London

Angus Dalgleish, Foundation Chair in Clinical Oncology + Research Director, St George's University, London

Dr Peter Daszak, President, Ecohealth Alliance Inc.

Jean de Foucauld, Senior Bio Regulatory Expert, Ceva Santé Animale

Dr Tanja De Gruijl, Professor of Translational Tumor Immunology, Vumc Cancer Center

Rob Dekker, CMC Team Lead, Janssen Infectious Diseases and Vaccines

Antu Dey, Senior Director, Research & Development, International AIDS Vaccine Initiative

Dr Joseph Domenech, Consultant, Former World Animal Health Organization (OIE) Chargé de Mission and FAO Head of Animal Head Service, O.I.E.

Dr Joseph Domenech, Consultant, Former World Animal Health Organization (OIE) Chargé de Mission and FAO Head of Animal Head Service, O.I.E.

Dr Bernd Eisele, Chief Executive Officer, Vakzine Projekt Management Gmbh

Dr Krishna M Ella, Founder and Chairman, Bharat Biotech International Ltd

Prof Susanna Esposito, Professor, University of Milan

Dr Katie Ewer, PI, Senior Immunologist-Malaria and Ebola Vaccine Trials, University of Oxford

Dr Amir Faridmoayer, Co-Founder & Vice President Discovery, LimmaTech Biologics AG

Prof Farzin Farzaneh, Professor of Molecular Medicine, King's College Hospital NHS Trust

Prof Farzin Farzaneh at Immune Profiling World Congress

Dr Sylvain Fleury, Chief Scientific Officer, Mymetics Corporation Sa

Dr Patrick Frayssinet, R&D Director, URODELIA

Dr Martin Friede, Coordinator, Initiative for Vaccine Research Immunization, Vaccines and Biologicals Department, WHO

Dr Dharanesh Gangaiah, Bacteriologist, Elanco Research Laboratories, Elanco Animal Health

Dr Bradley Garcia, Strategic Technology Leader, Roche Sequencing Solutions

Dr Nathalie Garcon, CEO/CSO, BIOASTER

Dr Nathalie Garcon, CEO/CSO, BIOASTER

Dr Ron Geven, Key Account Manager, BD Biosciences

Dr Glen Gifford, Chargé de mission, Oie (World Organisation For Animal Health)

Dr Gregory Glenn, President, Research and Development, Novavax

Prof David Goldblatt, Professor of Vaccinology and Immunology and Director of Clinical Research and Development, UCL

Dr Farshad Guirakhoo, CSO, GeoVax, Inc.

Dr Bart Haagmans, Working Group Leader, Department of Viroscience and Co-coordinator at ZAPI, Erasmus M.C.

Dr Bart Haagmans, Working Group Leader, Department of Viroscience and Co-coordinator at ZAPI, Erasmus M.C.

Dr Ali M. Harandi, Lab head, Dpt of Microbiology & Immunology, University of Gothenburg

Dr Vanessa Harris, Amsterdam Institute for Global Health and Development, University of Amsterdam

Richard Hatchett, CEO, CEPI

Marc Hoffman, CMO, Celerion

Henrik Hornsved, Senior Business Development, West Pharmaceutical Services Danmark As

Dr Renaud Jacquemart, Director Vaccines Process Sciences, Natrix Separations, now part of MilliporeSigma

Dr Rik Koopman, Global Technical Director, MSD Animal Health

Alexander Kort, Head Of Business Processes & Quality, Themis Bioscience GmbH

Dr Willem-Jan Krebber, COO, I.S.A. Therapeutics Bv

Dr Willem-Jan Krebber, COO, I.S.A. Therapeutics Bv

Dr David Krige, Head of Biomarkers, Immunocore Limited

Dr Jean Lang, Associate Vice President, R&D Projects Global Health, Partnerships & Funding, Sanofi Pasteur

Dr Hans Langedijk, Director of Subunit Vaccine Design, Janssen Vaccines & Prevention B.V.

Yves Leurquin, Head of Vaccine Market Access, Takeda Pharmaceuticals International Ag

Yotam Levin, Chief Executive Officer, NanoPass Technologies

Bernhard Liegl, VP Global Clinical Development, Celerion

Dr Stephen Lockhart, Vice President and Head of Europe and Asia-Pacific Vaccine Clinical Research and Development (VCRD), Pfizer

Patricia Londono-Hayes, Sr. Director / Head R&D Initiatives, Europe, Sanofi

Alfred Luitjens, Director Cell Technology at Batavia Biosciences, Batavia Biosciences

Dr Michael Makanga, Executive Director, European and Developing Countries Clinical Trials Partnership

Dr Anna-Karin Maltais, Chief Scientific Officer, Eurocine Vaccines AB

Reece Marillier, Research Scientist, iTeos Therapeutics

Phillipe Migraine, Director Regulatory Affairs, Merial

Phillipe Migraine at Immune Profiling World Congress

Dr Philip Minor, Former Deputy Director, Head of Virology, NIBSC & Member of the WHO Advisory Panel on Biological Standardization, National Institute for Biological Standards and Control

Dr Richard Mole, Commercialisation Manager, Moredun Institute

Prof Emanuele Montomoli, Prof in Public Health University of Siena & CSO, VisMederi

Dr Paul Moore, Vice President, Cell Biology & Immunology, Macro Genics Inc

Dr Dafne Mueller, Group Leader, Institute of Cell Culture and Immunotherapy, University of Stuttgart

Salim Mujais, Senior Vice President of Therapeutic Area Head, Immunology. Transplant, Infectious Disease, CNS & Pain, Astellas Pharma Inc

Salim Mujais at Immune Profiling World Congress

Salim Mujais, Senior Vice President of Therapeutic Area Head, Immunology. Transplant, Infectious Disease, CNS & Pain, Astellas Pharma Inc

Salim Mujais at Immune Profiling World Congress

Dr Eszter Nagy, Co-Founder, President and CSO, Arsanis Inc

Dr Shruthi Naik, Founder and VP, Comparative Oncology, Mayo Clinic and Foundation

Dr Charles Nicolette, Chief Scientific Officer, Argos Therapeutics

Dr Charles Nicolette at Immune Profiling World Congress

Dr Marta Nunes, Senior Scientist, University of the Witwatersrand

Prof Ab Osterhaus, Director, Research Center for Emerging Infections and Zoonoses (RIZ), University of Veterinary Medicine Hannover

Prof Albert Osterhaus, Director Research Center for Emerging Infections and Zoonoses (RIZ), University of Veterinary Medicine Hannover

Dr Marie Paule Kieny, Former Assistant Director General, World Health Organization

Dr Nikolai Petrovsky, Chairman, Vaxine Pty.

Dr Nikolai Petrovsky, Chairman, Vaxine Pty.

Dr Nikolai Petrovsky, Chairman, Vaxine Pty.

Dr Kai Pinkernell, Chief Medical Officer & Senior Vice President of Medical Affairs, Medigene Ag

Dr Olga Pleguezuelos, CSO and Project Manager, SEEK

Ivo Ploemen, Program Manager, Intravacc

Dr Gregory A. Poland, Director of Mayo Vaccine Research Group, Mayo Clinic and Foundation

Dr Jan Poolman, Head Bacterial Vaccine Discovery and Early Development, Janssen

Dr Rino Rappuoli, Chief Scientist, GSK Vaccines

Susanne Rauch, Senior Scientist, CureVac Gmbh

Susanne Rauch at Immune Profiling World Congress

Dr Sai Reddy, Assistant Professor of Bimolecular Engineering, E.T.H. Zurich

Dr Steven Reed, President, Founder & CEO, Infectious Disease Research Institute

Zarifah Reed, Medical Director, Sentinext Therapeutics

Prof Helen Rees, Chair and Executive Director, Wits Reproductive Health and HIV Institute

Dr Laura Rosa Brunet, Former Chief Scientific Officer, Immodulon Therapeutics Ltd

Armin Saalmueller, Professor, University of Veterinary Medicine

Armin Saalmueller at Immune Profiling World Congress

Dr Jerald Sadoff, Senior Advisor Vaccine Development, Janssen Infectious Diseases and Vaccines

Dr Nathaly Samy, Senior Vice President - Clinical Development, Bavarian Nordic

Dr Melanie Saville, VP, Head of Late Development, Clinical and Medical Affairs, Janssen Vaccines & Prevention B.V.

Dr Emmett Schmidt, Executive Director, Clinical Research, Merck Research Laboratories - Oncology, Merck & Co.

Dr Ruprecht Schmidt Ott, European Director for Scientific Affairs & Public Health, GSK Vaccines

Dr Randolph Seidler, Managing Director, Veterinary Research Centre & VP, Global Head of BD, Boehringer Ingelheim Animal Health Gmbh

Dr Vivek Shinde, Director of Clinical Development Lead, Pediatric and Older Adult Rsv Vaccines, Novavax

Scot Shoemaker, Senior Director, Takeda

Bruno Speder, Head of Clinical Regulatory Affairs, S.G.S. Life Science Services

Dr Artur Summerfield, Proffesor of Immunology, Group Head, Institute of Virology and Immunology

Prof Adel Talaat, Professor of Microbiology, University of Wisconsin-Madison

Dr Adel Talaat, Professor of Microbiology, University of Wisconsin-Madison

Dr John Tan, Senior Scientist, Technology Innovation, Roche Sequencing Solutions

Dr Frédéric Tangy, Director of R&D, CNRS, Institut Pasteur

Dr Peter Timmerman, Chief Scientific Officer, Pepscan Therapeutics

Dr Peter Timmerman at Immune Profiling World Congress

Dr Peter Timmerman, Chief Scientific Officer, Pepscan Therapeutics

Dr Sean Tucker, CSO and VP Research, Vaxart

Dr Bernard Vallat, Honorary Director General, Office International Des Epizooties

Dr Carel van Baalen, Director R&D, Viroclinics Biosciences

Thierry Van Den Berg, Head of the Department on Animal Infectious Diseases, Veterinary and Agrochemical Research Centre

Dr Marcelle Van Mechelen, Senior Scientific Advisor, Caprion Biosciences SA

Prof Martin Vordermeier, Team Leader, Animal Health and Veterinary Laboratories Agency

Prof Martin Vordermeier, Team Leader, Animal Health and Veterinary Laboratories Agency

Dr Adrian Wildfire, Project Director - Infectious Diseases & Viral Infection Unit, SGS Life Science Services

Yariv Wine, Senior Lecturer, Tel Aviv University

Dr Vidadi Yusibov, Executive Director, Fraunhofer Center for Molecular Biotechnology